For investigative teams seeking high-purity Elamipretide for laboratory research, sourcing verified, low-endotoxin compounds is essential for maintaining experimental reproducibility. PX1 Research supplies USA-manufactured Elamipretide accompanied by comprehensive third-party analytical documentation for in vitro and animal model applications.
For investigative teams seeking high-purity Elamipretide for laboratory research, sourcing verified, low-endotoxin compounds is essential for maintaining experimental reproducibility. PX1 Research supplies USA-manufactured Elamipretide accompanied by comprehensive third-party analytical documentation for in vitro and animal model applications.
Elamipretide (also known as SS-31 or MTP-131) for sale is available to qualified academic, clinical, and institutional laboratories as a high-purity research chemical. Designated strictly for in vitro assays and preclinical animal models, research-grade Elamipretide requires verified sequence fidelity, high-performance liquid chromatography (HPLC) purity exceeding 98%, and documented endotoxin limits prior to experimental integration.
When purchasing Elamipretide (SS-31), investigative teams must prioritize analytical transparency. PX1 Research provides batch-specific Certificate of Analysis (COA) documentation generated by independent ISO 17025 accredited laboratories. Every lot undergoes rigorous reverse-phase HPLC (RP-HPLC) to confirm chemical purity and electrospray ionization mass spectrometry (ESI-MS) to verify molecular weight, ensuring that experimental variables remain tightly controlled across long-term studies.
Elamipretide is a cell-permeable, synthetic tetrapeptide with the amino acid sequence D-Arg-Dmt-Lys-Phe-NH2 (where Dmt represents 2',6'-dimethyltyrosine). Structural analysis demonstrates that its unique alternating aromatic-basic amino acid motif grants it a strong lipophilic cation nature. This allows the molecule to cross the outer mitochondrial membrane independently of membrane potential.
Preclinical investigations demonstrate that Elamipretide selectively targets and binds cardiolipin, an essential phospholipid localized predominantly within the inner mitochondrial membrane (IMM). Cardiolipin plays a critical structural role in organizing respiratory chain complexes into functional supercomplexes (respirasomes). By electrostatic and hydrophobic interactions with cardiolipin's negatively charged headgroups and acyl chains, Elamipretide stabilizes membrane architecture and prevents cardiolipin peroxidation under conditions of cellular stress.
In vitro data indicate that by stabilizing cardiolipin at the inner mitochondrial membrane, Elamipretide optimizes electron flux through respiratory Complexes I, II, III, and IV. In isolated mitochondrial preparations, treatment with Elamipretide has been shown to reduce electron leak at Complex I and III, thereby maintaining the proton motive force necessary for efficient oxidative phosphorylation.
Preclinical rodent models of metabolic stress and ischemia highlight that cardiolipin stabilization by Elamipretide preserves ATP production while simultaneously suppressing the overproduction of reactive oxygen species (ROS). Furthermore, by preventing cardiolipin oxidation, Elamipretide inhibits the release of cytochrome c into the cytosol, a key event in the initiation of the intrinsic apoptotic cascade. These mechanisms position the compound as a fundamental tool in mitochondrial research peptides science.
Evaluating a supplier when sourcing high-purity analytical compounds requires assessing specific quality parameters. Because subtle impurities or remnant organic solvents can alter mitochondrial bioenergetic readouts, laboratory researchers must demand complete analytical verification.
At PX1 Research, every batch of Elamipretide is manufactured in cGMP-compliant US facilities and subjected to a multi-tiered analytical screening process:
• RP-HPLC Analysis: Confirms chromatographic purity, ensuring that related peptide impurities or truncated sequences do not exceed 2.0% total area.
• Mass Spectrometry (ESI-MS): Verifies exact monoisotopic mass to confirm peptide identity.
• Endotoxin Testing: Enforces strict bacterial endotoxin thresholds (typically <0.01 EU/mg) using chromogenic LAL assays to prevent non-specific inflammatory signaling in cell culture or animal assays.
• Residual Solvent & Heavy Metal Analysis: Ensures complete removal of trifluoroacetic acid (TFA) salts and synthesis reagents that could confound enzymatic or mitochondrial assays.
To understand the distinct role of Elamipretide within experimental designs, researchers frequently compare it against other mitochondrial-active agents within the PX1 Research library. Unlike broad-spectrum antioxidants that non-selectively scavenge ROS in the cytosol, Elamipretide acts directly at the IMM cardiolipin interface.
When evaluated alongside mitochondrial-derived peptides, key functional differences emerge. For instance, MOTS-c is a mitochondrial ORF-derived peptide that primarily regulates nuclear gene expression and metabolic homeostasis via AMPK pathways under stress. Similarly, Humanin functions predominantly as a cytoprotective factor that interacts with extracellular receptors and cytosolic bax proteins to prevent apoptosis. In contrast, Elamipretide (SS-31) acts biophysically at the lipid-protein interface of the inner mitochondrial membrane, directly modulating electron transport chain efficiency and supercomplex stability.
Elamipretide is supplied as a lyophilized, sterile powder to maximize long-term shelf stability. For in vitro and in vivo laboratory protocols, standard reconstitution techniques must be followed under aseptic conditions within a certified laminar flow hood.
• Primary Solvents: Lyophilized Elamipretide exhibits high solubility in sterile lab-grade water, phosphate-buffered saline (PBS, pH 7.4), or 0.9% sterile saline. For assays requiring low-volume, high-concentration stock solutions, concentrations up to 10 mg/mL are readily achieved.
• Dissolution Protocol: Allow the vial to equilibrate to room temperature before reconstitution to prevent moisture condensation. Gently add the diluent along the inner glass wall of the vial. Swirl gently; do not vortex vigorously, as excessive shear forces can disrupt peptide secondary structures.
• Working Dilutions: Once reconstituted in aqueous buffer, working solutions should be diluted directly into culture media or assay buffers immediately prior to experimental procedures.
Maintaining peptide integrity over the duration of an experimental timeline requires adherence to strict storage protocols detailed in our peptide storage and handling guides.
• Lyophilized Powder: Store at -20°C for short-to-medium term storage (up to 12 months) or at -80°C for long-term storage. Ensure the container seal remains intact to protect against atmospheric humidity.
• Reconstituted Solutions: Liquid aliquots should be divided into single-use volumes using polypropylene or low-protein-binding microcentrifuge tubes to prevent adsorption loss. Store liquid aliquots at -80°C. Avoid repeated freeze-thaw cycles, which accelerate peptide bond cleavage and reduce functional titer.
• Degradation Vectors: Avoid exposing reconstituted solutions to direct light or elevated temperatures above 37°C for extended periods, as the 2',6'-dimethyltyrosine residue can undergo oxidative degradation if exposed to prolonged UV light.
Literature evaluating Elamipretide spans several disciplines focused on bioenergetics, cellular aging, and organ preservation models. Researchers utilize the compound to probe fundamental questions regarding mitochondrial dysfunction:
• Ischemia-Reperfusion Injury Models: In rodent models of renal and cardiac ischemia, Elamipretide administration prior to or during reperfusion has been studied for its capacity to suppress ROS surges, preserve cristae structure, and mitigate tissue necrosis.
• Neurodegenerative In Vitro Assays: Investigators employ Elamipretide in neuronal cell lines (such as SH-SY5Y or primary cortical neurons) to evaluate protection against amyloid-beta or alpha-synuclein-induced mitochondrial fragmentation.
• Skeletal Muscle Bioenergetics: Rodent studies examining age-related sarcopenia assess how targeted cardiolipin protection affects force production, mitochondrial coupling efficiency, and fatigue resistance in aged muscle fibers.
PX1 Research operates dedicated logistics to support academic labs, biotechnology firms, and contract research organizations (CROs). When establishing an institutional research account, procurement departments gain access to bulk lot reservations, custom packaging configurations, and priority shipping schedules.
All orders ship directly from USA-based facilities located in California and Arizona. Orders placed Monday through Friday prior to cutoff times are dispatched same-day under temperature-controlled shipping conditions to maintain compound stability during transit.
What is the primary mechanism of Elamipretide (SS-31) in laboratory research?
Elamipretide is a mitochondria-targeted tetrapeptide that selectively binds to cardiolipin at the inner mitochondrial membrane. Preclinical research shows this interaction stabilizes supercomplex structure, optimizes electron transport chain efficiency, increases ATP production, and reduces reactive oxygen species (ROS) formation.
Is Elamipretide sold by PX1 Research intended for human administration?
No. All products offered by PX1 Research, including Elamipretide, are strictly intended for laboratory research, in vitro assays, and preclinical animal models. They are not for human or veterinary use, medical diagnosis, or therapeutic applications.
What analytical purity level is guaranteed for Elamipretide?
PX1 Research provides Elamipretide verified at ≥98% chemical purity using Reverse-Phase High-Performance Liquid Chromatography (RP-HPLC) and Electrospray Ionization Mass Spectrometry (ESI-MS). Every batch includes a lot-specific Certificate of Analysis.
What are the bacterial endotoxin limits for PX1 Research Elamipretide?
Every lot of Elamipretide undergoes chromogenic LAL testing to ensure endotoxin levels remain strictly below <0.01 EU/mg, preventing non-specific cellular signaling or cytokine induction during sensitive in vitro and in vivo assays.
How should lyophilized Elamipretide be stored upon arrival?
Upon receipt, lyophilized Elamipretide powder should be stored at -20°C for short-term preservation or -80°C for extended stability. Reconstituted aliquots must be frozen at -80°C in single-use volumes to avoid degradation from freeze-thaw cycles.
What diluents are recommended for reconstituting Elamipretide in a lab setting?
Elamipretide is freely soluble in sterile lab-grade water, phosphate-buffered saline (PBS, pH 7.4), or 0.9% normal saline. Solvents should be added gently without vigorous vortexing to preserve peptide structural integrity.
Where is PX1 Research Elamipretide manufactured and shipped from?
PX1 Research compounds are synthesized in cGMP-compliant US facilities and shipped directly from fulfillment hubs in California and Arizona, with same-day shipping available for orders placed Monday through Friday.
How does Elamipretide differ from MOTS-c or Humanin in preclinical studies?
Elamipretide acts direct biophysically on inner mitochondrial cardiolipin to optimize electron transport and respiratory supercomplexes. In contrast, MOTS-c acts via nuclear translocation and metabolic gene signaling, while Humanin acts primarily as a cytoprotective factor through cytosolic and cell-surface receptor pathways.
All products are sold strictly for laboratory and research use only. Not for human or veterinary use, diagnosis, treatment or consumption. Statements have not been evaluated by the FDA.